BMs The Clinical Institute Withdrawal Assessment Alcohol (CIWA-Ar, see page 4-6)
|
|
- Dylan Stokes
- 5 years ago
- Views:
Transcription
1 Alchl Withdrawal Guideline Intrductin As a Trust, it is vital we mnitr patients with knwn alchl dependence clsely. Nt ding s can result in serius and life threatening cmplicatins such as withdrawal and cmplicatins such as delirium tremens (DT), seizures r Wernicke s encephalpathy. Recgnising Key Symptms Alchl withdrawal cmmnly appears between -7 hurs after last alchl use. Risk factrs fr severe withdrawal include: - High alchl Intake (>1 units a day) - Previus histry f severe withdrawal/seizures/dts - Use f psychtrpic drugs and/r substances f misuse - Pr physical health - High level f anxiety - Fever/sweating/tachycardia - Insmnia Symptms f active withdrawal include: Mild Mderate Severe Mild anxiety Marked anxiety Marked anxiety and increasing cnfusin Insmnia Insmnia and irritability Insmnia and irritability Slight sweating Prfuse sweating Prfuse sweating Tachycardia (>100) Tachycardia (>100) Tachycardia ( >10) Fever (>7) Fever (>7) Fever (>7) Nausea, vmiting and diarrhea Raised BP Raised BP Restlessness and tremr Hallucinatins and delusins Lss f balance Cnvulsins Unsteady walk cmpared t befre (ataxia) Investigatins Observatins (BP, pulse, temperature) - three times a day. Alchl intake & time f last drink Blds Full bld cunt: anaemia, hazardus drinking (raised MCV) Urea & electrlytes: ptassium must be checked if there is arrhythmia Liver functin tests assess severity f liver disease Cltting functin (e.g. INR) disrupted in liver failure Thyrid functin a differential diagnsis f arrhythmia Magnesium & phsphate refeeding syndrme ECG Level bservatins Alchl Withdrawal Guideline Page 1 f 7 Versin 1.0 September 018
2 BMs The Clinical Institute Withdrawal Assessment Alchl (CIWA-Ar, see page 4-) Fixed dse reductin regimen Chlrdiazepxide is the benzdiazepine used in the majrity f centres fr patients with alchl withdrawal. It is cnsidered t have a lw dependence-frming ptential, if the patient has significant hepatic impairment/liver failure then a shrt acting benzdiazepine is preferred e.g. lrazepam (1mg lrazepam apprximately equivalent t mg f chlrdiazepxide). Ensure patient is nt prescribed ther ral benzdiazepines (fr agitatin) alng with chlrdiazepxide. Assess the severity f alchl withdrawal using CIWA-Ar (see pg 4-), based n the scre determine severity f dependence and therefre the fixed dse regime required (see table belw). If still intxicated d nt prescribe benzdiazepines. If elderly cnsider halving the dses f chlrdiazepxide CIWA- Ar < >0 Severity f Mild Mderate Mderate-Severe Severe Dependence (treatment nt required) (treatment may nt be required) Starting Dse f 0 mg 0mg 40mg Chlrdiazepxide Day 1mg mg mg Day 10mg 0mg 0mg Day 4 mg 1mg mg Day mg BD 10mg 0mg Day 10mg BD 1mg Day 7 mg BD 10mg Day 8 10mg TDS Day 9 10mg BD Day 10 mg BD PRN Chlrdiazepxide 10-0mg shuld be written up with a maximum f 0mg/day including regular. Patients shuld nt be discharged n chlrdiazepxide unless under the care f an fficial alchl withdrawal scheme. Thiamine supplementatin Prphylaxis f Wernicke- Krsakff syndrme Alchl withdrawal seizures Oral likely t be sufficient - Thiamine 0mg Pabrinex IM 1 pair OD fr day Day discharge Thiamine 0mg Pabrinex IM 1 pair OD fr days Day discharge Thiamine 0mg Diazepam 10mg PR Pabrinex IM 1 pair OD fr days Day discharge Thiamine 0mg Alchl Withdrawal Guideline Page f 7 Versin 1.0 September 018
3 Mnitr CIWA-Ar Scre daily: 1) If the scre decreases, cntinue with reducing regimen ) If the scre remains the same r increases, cnsider reverting back t previus dse r increase accrding t scre severity. Vitamins Preventin f Wernicke-Krsakff Syndrme Pabrinex Intramuscular High Ptency (IMHP). 1 pair f ampules ONCE a day fr days. The cntents f each pair f ampules shuld be drawn up int a syringe t mix just befre use and injected slwly. Recrd BP and pulse befre and after giving Pabrinex. SITE OF INJECTION: HIGH INTO THE GLUTEAL MUSCLE CM BELOW THE ILIAC CREST. Als give ral supplementatin f thiamine 0mg nce the curse f Pabrinex is cmpleted. On discharge lwer t Thiamine 0mg BD. IM PABRINEX HAS A LOWER INCIDENCE OF ANAPHYLACTIC REACTIONS THAN IV AND THE RISK REMAINS LOW HOWEVER FACILITIES FOR TREATING ANAPHYLAXIS REACTIONS SHOULD BE PRESENT. Cmplicatins 1) Delirium Tremens - Mrtality risk f up t 0% if unrecgnised. - Clinical features include cnfusin and disrientatin, severe tremr, sweating, fluctuating BP and pulse, visual and auditry as well as delusinal beliefs. - Cnsider transfer t acute hspital urgently. ) Wernicke s Encephalpathy - Mrtality risk f up t 1% if unrecgnised and can result in permanent brain damage (Krsakff s psychsis). - Clinical features include acute cnfusin, ataxia and paralysis f eye muscles ccurs in 10% f patients. Other features include unexplained hyptensin and hypthermia, memry disturbance and unsteadiness. - Cnsider transfer t acute hspital urgently fr IV Pabrinex. ) Withdrawal Seizures - Manage with 10mg rectal diazepam. - RING 999 Alchl Withdrawal Guideline Page f 7 Versin 1.0 September 018
4 CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL (CIWA-Ar) NAUSEA AND VOMITING Ask D yu feel sick t yur stmach? Have yu vmited? Observatins. 0 n nausea and n vmiting 1 mild nausea with n vmiting 4 intermittent nausea with dry heaves 7 cnstant nausea, frequent dry heaves and vmiting TREMOR Arms extended and fingers spread apart. Observatins 0 n tremr 1 nt visible, but can be felt fingertip t fingertip 4 mderate, with patient s arms extended 7 severe, even with arms nt extended PAROXYSMAL SWEATS - Observatin 0 n sweat visible 1 barely perceptible sweating, palms mist 4 beads f sweat bvius n frehead 7 drenching sweats ANXIETY Ask D yu feel nervus? Observatin. 0 n sweat visible 1 barely perceptible sweating, palms mist 4 beads f sweat bvius n frehead 7 equivalent t acute panic states as seen in severe delirium r acute schizphrenic reactins AGITATION Observatin 0 nrmal activity 1 smewhat mre than nrmal activity 4 mderately fidgety and restless 7 paces back and frth during mst f the interview, r cnstantly thrashes abut TACTILE DISTURBANCES Ask Have yu any itching, pins and needles sensatins, any burning, any numbness, r d yu feel bugs crawling n r under yur skin? Observatin. 0 nne 1 mild nausea with n vmiting mild itching, pins & needles, burning & numbness mderate itching, pins & needles, burning r numbness 4 mderately severe severe extremely severe 7 cntinuus AUDITORY DISTURBANCES Ask Are yu mre aware f sunds arund yu? Are they harsh? D they frighten yu? Are yu hearing anything that is disturbing t yu? Are yu hearing things yu knw are nt there? Observatin. 0 nt present 1 very mild harshness r ability t frighten mild harshness r ability t frighten mderate harshness r ability t frighten 4 mderately severe severe extremely severe 7 cntinuus VISUAL DISTURBANCES Ask Des the light appear t be t bright? Is its clr difference? Des it hurt yur eyes? Are yu seeing anything that is disturbing t yu? Are yu seeing things yu knw are nt there? Observatin. 0 nt present 1 very mild sensitivity mild sensitivity mderate sensitivity 4 mderately severe severe extremely severe 7 cntinuus HEADACHE, FULLNESS IN HEAD Ask Des yur head feel different? Des it feel like there is a band arund yur head? D nt rate fr dizziness r lightheadedness. Otherwise, rate severity. 0 nt present 1 very mild mild mderate 4 mderately severe severe very severe 7 extremely severe ORIENTATION AND CLOUDING OF SENSORIUM Ask What day is this? Where are yu? Wh am I? 0 riented and can d serial additins 1 cannt d serial additins disriented fr date by n mre than calendar days disriented fr date by mre than calendar days 4 disriented fr place/r persn Alchl Withdrawal Guideline Page 4 f 7 Versin 1.0 September 018
5 SCORES NAME: DOB: 0-9: MILD WITHDRAWAL SURNAME: NHS NO: 10-19: MODERATE WITHDRAWAL (CONTACT DOCTOR) >0: SEVERE WITHDRAWAL (CONTACT DOCTOR URGENTLY) CIWA-Ar Scre Table Cmplete n initiatin and at least daily thereafter as required ADDRESS: CIWA-Ar scre increases, alert dctr. Symptms Nausea (0,1,4,7) Tremr (0,1,4,7) Sweats (0,1,4,7) Anxiety (0,1,4,7) Date/Time Agitatin (0,1,4,7) Tactile Hallucinatins (0-7) Auditry Hallucinatins (0-7) Visual Hallucinatins (0-7) Headache (0-7) Orientatin (0-4) Ttal Scre Nurse/Dctr Signature Alchl Withdrawal Guideline Page f 7 Versin 1.0 September 018
6 CIWA-Ar Scre with Reference Scres Nausea/Vmiting NONE Mild nausea, n vmiting Tremr Sweats NONE NONE Nt visible, but can be felt fingertip t fingertip Barely sweating, palms mist Anxiety NONE Mild anxiety Intermittent nausea with dry heaves Mderate, with patient s arms extended Sweat n frehead Mderately anxius, r guarded Cnstant nausea, frequent dry heaves & vmiting Severe, even with arms nt extended Drenching sweats Equivalent t acute panic states Agitatin NONE Mre than nrmal activity Mderately restless Paces back and frth Tactile Hallucinatins Auditry Hallucinatins NONE Very mild itching, pins and needles, burning r numbness Mild itching, pins and needles, burning r numbness Mderate itching, pins and needles, burning r numbness NONE Very mild Mild Mderate Visual Hallucinatins NONE Very mild Mild Mderate Mderately severe Mderately severe Mderately severe Severe Severe Severe Extremely severe Extremely severe Extremely severe Cntinuus Cntinuus Cntinuus Headache NONE Very mild Mild Mderate Mderately severe Severe Very severe Extremely severe Orientatin NONE Uncertain f date Incrrect date < days Incrrect date > days Disriented fr place/persn Alchl Withdrawal Guideline Page f 7 Versin 1.0 September 018
7 Bibligraphy Taylr, D. Patn, C. Kapur, S. The Maudsley Prescribing Guidelines. 1 th Editin. Wiley Blackwell. Chichester; 01. Natinal Institute f Clinical Excellence (011). Alchl-use disrders: diagnsis, assessment and management f harmful drinking and alchl dependence. NICE clinical guideline CG11. Lingfrd-Hughes AR, Welch S, Peters L, et al. BAP updated guidelines: evidence-based guidelines fr the pharmaclgical management f substance abuse, harmful use, addictin and cmrbidity: recmmendatins frm BAP. Jurnal f Psychpharmaclgy 01. Guidelines written by BCPFT Pharmacy Team: September 018 Next Review Date: Sept 01 Alchl Withdrawal Guideline Page 7 f 7 Versin 1.0 September 018
Alcohol withdrawal. Clinical features
Alcohol withdrawal Clinical features Severity increase with amount consumed; uncommon with < drinks per day. Predictable pattern: patients with previous withdrawal seizures are at high risk for recurrence.
More informationStabilization Algorithm
VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders Stabilization Algorithm Stabilization Pocket Card 1 Patient and Time Information Clinical Institute Withdrawal Assessment
More informationALCOHOL WITHDRAWAL GUIDELINES
ALCOHOL WITHDRAWAL GUIDELINES Policy author Accountable Executive Lead Approving body Policy reference Dr M Lewis, Gastroenterologist; Professor J A Vale, Clinical Toxicologist; Dr D A Robertson, Alcohol
More informationAPPENDIX 7 CLINICAL INSTITUTE NARCOTIC ASSESSMENT (CINA) SCALE FOR WITHDRAWAL SYMPTOMS
APPENDIX 7 CLINICAL INSTITUTE NARCOTIC ASSESSMENT (CINA) SCALE FOR WITHDRAWAL SYMPTOMS The Clinical Institute Narcotic Assessment (CINA) Scale measures 11 signs and symptoms commonly seen in patients during
More informationLead for Gastroenterology Lee Dodge Alcohol Liaison 03/03/2015. Clive Gibson Safeguarding Adults Lead Nurse 03/03/2015
Acute Alcohol Withdrawal Management for Adult Inpatients Type: Clinical Guideline Register No: 1409 Status: Public on ratification Developed in response to: Best Practice Contributes to CQC Outcome number:
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationAssessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance
CONCISE GUIDANCE Clinical Medicine 01, Vol 1, No : 71 Assessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance Author head name Stephen Stewart
More informationAppendix C Guidelines for treating status epilepticus in adults and children
Appendix C Guidelines fr treating status epilepticus in adults and children 1.1 Treating cnvulsive status epilepticus in adults General measures 1st stage (0 10 minutes) Secure airway and resuscitate Administer
More informationAlcohol Withdrawal Guidelines
SH CP 197 Alcohol Withdrawal Guidelines Summary: Keywords: Target Audience: Identification, assessment and management of alcohol dependence and harmful alcohol use in people presenting for assessment or
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More information/0515 Medication Guide Aripiprazole Tablets
8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This
More informationPharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01. Planned review: December 2017
Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01 V01 issued: Issue 1- Dec 14 Issue 2 April 17 Planned review: December 2017 PPT-PGN
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationSasan Dabiri, MD, Assistant Professor
Sasan Dabiri, MD, Assistant Prfessr Department f Otrhinlarynglgy Head & Neck Surgery Amir Alam Hspital Tehran University f Medical Sciences March 2016 s - d a b i r i @ t u m s. a c. i r Backgrund Diagnsis
More information454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place
MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and
More informationSuicidal thoughts or actions:
MEDICATION GUIDE Venlafaxine (VEN la fax een) Hydrchlride Extended-release Capsules USP Read the Medicatin Guide that cmes with venlafaxine hydrchlride extended-release capsulesbefre yu start taking them
More informationPharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02. Planned review: Dec 2020
Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02 Issue No: Issue 1- Dec 17 Planned review: Dec 2020 PPT-PGN 22 Part of NTW(C)38 Pharmacological
More informationWARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES
INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least
More informationUnderstanding Blood Counts
Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health
More informationPart 1 describes the reasoning and recommendations up to node 2 of the algorithm.
Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:
More informationo New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe.
MEDICATION GUIDE FLUOXETINE CAPSULES, USP (fl xʹ e teen) 10 mg and 20 mg Read the Medicatin Guide that cmes with fluxetine capsules befre yu start taking it and each time yu get a refill. There may be
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationAlcohol withdrawal including the Symptom triggered CIWA score Management
Alcohol withdrawal including the Symptom triggered CIWA score Management Classification: Policy Lead Author: Ruth Brown Alcohol specialist Nurse Additional author(s): Hailey Pennington Authors Division:
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationNEW PATIENT QUESTIONNAIRE-ADULT
3700 WASHINGTON AVENUE EVANSVILLE, IN 47750 (812) 485-7680 NEW PATIENT QUESTIONNAIRE-ADULT PART 1. PATIENT INFORMATION Name Hme Phne Date f Birth Scial Security Number Wrk Phne Tday s Date Physicians Caring
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationAdvantage EAP Employee Assistance Program
Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse
More informationIschemic heart disease (angina/chest pain)
Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember
More informationBP Thresholds for Medical Review
BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationMEDICATION GUIDE. (canagliflozin) Tablets
MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can
More informationMy Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)
My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationGuidelines for the Admission of Children and Young People with an Eating Disorder
Guidelines fr the Admissin f Children and Yung Peple with an Eating Disrder This dcument is designed t be used by clinicians lcated in hspitals f wards withut specialist eating disrder facilities, t guide
More informationPATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.
PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr
More informationCMBHS Clinical Management of Behavioral Health Services
Client: CMBHS Clinical Management of Behavioral Health Services Detoxification Assessment Assessment Information (te: All are Required fields) Assessment Number Assessment Date Assessment Type Contact
More informationAccess to Heme Treatment in Canada - Survey 2018
Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment
More informationDo you have any of the symptoms listed below? Please circle all that apply.
D yu have any f the symptms listed belw? Please circle all that apply. Parkinsn s Symptms: Truble walking Falls Feet sticking t the flr Tremr Medicatins wearing ff Truble sleeping Vivid dreams Thrashing
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.
More informationPATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:
PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationMedication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection
Medicatin Guide SIGNIFOR [sig-na-fr] (pasiretide) Injectin Read this Medicatin Guide befre yu start using SIGNIFOR and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationVaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE
Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationLorraine Wilson, 74 years of age, is admitted. Alcohol Withdrawal. During Hospitalization. Early recognition and consistent intervention are critical.
1.9 h o u r s Continuing Education Withdrawal During Hospitalization Early recognition and consistent intervention are critical. Overview: For a chronic drinker, sudden alcohol withdrawal because of an
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SUBSTANCE DEPENDENCY For full details of the of the medication discussed in this formulary including side effects,
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationMANAGEMENT AND DETOXIFICATION FOR GAMMA- HYDROXYBUTYRATE (GHB) AND GAMMA-BUTARYL LACTONE (GBL) GUIDELINES SEPTEMBER 2017
MANAGEMENT AND DETOXIFICATION FOR GAMMA- HYDROXYBUTYRATE (GHB) AND GAMMA-BUTARYL LACTONE (GBL) GUIDELINES SEPTEMBER 2017 Policy title Management and Detoxification for GHB and GBL Policy PHA61 reference
More informationTitle Alcohol Withdrawal Management Guidelines
Document Control Title Alcohol Withdrawal Management Guidelines Author Directorate Date Version Issued 0.1 Dec 2009 0.2 Mar 2010 0.3 Nov 2010 Status Draft 0.4 Sep 2015 1.0 Jan 2016 2.0 Nov Final 2018 Main
More informationBefore Your Visit: Mohs Skin Cancer Surgery
Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with
More informationMEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP
MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets
More informationPaediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead
Paediatric Sepsis Frm Sinéad Hrgan SSWHG Sepsis Lead www.hse.ie/sepsis Definitin A life-threatening rgan dysfunctin due t a dysregulated hst respnse t infectin N cnfirmatry test Bld cultures are psitive
More informationThe Dizziness Handicap Inventory ( DHI )
The Dizziness Handicap Inventry ( DHI ) P1. Des lking up increase yur prblem? Yes E2. Because f yur prblem, d yu feel frustrated? Yes F3. Because f yur prblem, d yu restrict yur travel fr business r recreatin?
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationGuidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust
Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Authors: Dr Aftab Ala, Consultant Gastroenterologist & Hepatologist Dr Tasneem Pirani, ST4 in
More informationAlcohol Detoxification (Inpatient) Prescribing Guidelines
Alcohol Detoxification (Inpatient) Prescribing Guidelines Author: Sponsor/Executive: Responsible committee: Consultation & Approval: (Committee/Groups which signed off the procedure, including date) This
More informationUnderstanding and Recognizing Anxiety
Understanding and Recgnizing Anxiety Mst peple d nt recgnize their anxiety fr what it is, and instead think there is smething mre serius ging n. Myth: Reading, thinking, and learning abut anxiety will
More informationEating Disorders. what do GPs need to know? John O Brien May 2016
Eating Disrders what d GPs need t knw? Jhn O Brien May 2016 Overview Eating, weight and eating disrders Case scenari Hw t spt them When t refer Management pre and pst referral Eating and weight Adlescence
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationPrinted copies of this document may not be up to date, obtain the most recent version from Author Position
Printed cpies f this dcument may nt be up t date, btain the mst recent versin frm www.cats.nhs.uk Children s Acute Transprt Service Clinical Guidelines Diabetic Ketacidsis Dcument Cntrl Infrmatin Authr
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationPediatric Health History Form
Pediatric Health Histry Frm Child s Name Date f Birth Mther s Name Father s Name Parent Cncerns - Please explain any ther cncerns r questins yu have abut yur child Des yur child have any allergies? Yes
More informationHYPERTENSION AN OVERVIEW. Compiled by. Campbell M Gold (2008) CMG Archives --()-- IMPORTANT
HYPERTENSION AN OVERVIEW Cmpiled by Campbell M Gld (2008) CMG Archives http://campbellmgld.cm IMPORTANT The health infrmatin cntained herein is nt meant as a substitute fr advice frm yur physician, r ther
More informationPatient Information Packet Date:
Patient Infrmatin Packet Date: We knw paperwrk is nt fun, but thank yu s much fr taking the time! Last Name: First Name: MI Address: Phne: City State: Zip Cde: Mbile: D.O.B: / / Scial Security: / / Email:
More informationNew Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)
New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationHealth for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y
Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More informationPART III: CONSUMER INFORMATION
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationNorthern Ireland Alcohol Use Disorders Care Pathway. management in the acute hospital setting
Northern Ireland Alcohol Use Disorders Care Pathway management in the acute hospital setting Main Content 1. Introduction 2 2. Alcohol Withdrawal Syndrome 3 2.1. Delirium tremens 3 2.2. Seizures 4 2.3.
More informationCancer Association of South Africa (CANSA) Fact Sheet on Essential Thrombocythaemia
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet n Essential Thrmbcythaemia Intrductin Essential thrmbcythaemia (ET) is nt a type f bld cancer as there are n cancerus cells. It is cnsidered a chrnic haematlgical
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationManaging the Symptoms of Stroke
Unit 26: Recgnising and Managing the Symptms f Strke Unit reference number: F/616/7312 Level: 2 Unit type: Optinal Credit value: 3 Guided learning hurs: 28 Unit summary A strke can be a life-threatening
More informationName of procedure: Removal of submandibular salivary gland
Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationPackage leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate
Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet
More informationTop 10 Causes of Disability
Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins
More informationWithdrawal.
Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts General
More informationTendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones.
Medicatin Guide LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION, 25 mg/ml and LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION in 5% Dextrse fr Intravenus Use Read this Medicatin Guide befre yu start taking levflxacin
More informationMEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV
MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationMEDICATION GUIDE. Reference ID:
MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe
More informationThank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!
Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please
More informationIntroduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65)
Intrductin t Psychlgical Disrders (Myers fr AP 2 nd Editin, Mdule 65) Why are we s interested in learning abut psychlgical disrders? The Wrld Health Organizatin reprts that peple suffer frm mental r behavir
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationPackage leaflet: Information for the user. CHAMPIX 0.5 mg film-coated tablets CHAMPIX 1 mg film-coated tablets Varenicline
Package leaflet: Infrmatin fr the user CHAMPIX 0.5 mg film-cated tablets CHAMPIX 1 mg film-cated tablets Varenicline Read all f this leaflet carefully befre yu start taking this medicine because it cntains
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationFLORIDA ORTHOPAEDIC INSTITUTE SPINE FIRST VISIT QUESTIONNAIRE
FLORIA ORTHOPAEIC INSTITUTE SPINE FIRST VISIT QUESTIONNAIRE Please circle answers t questins that pertain t yur prblem. Yu may select mre than ne answer per questin. This infrmatin will help get an accurate
More informationGUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD
GUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD Policy Details NHFT document reference MMG027/HMP Version 1 Date Ratified May 2017 Ratified by HMP Bedford Drugs and Therapeutics Committee Implementation
More informationAsthma inhalers, medicines and treatments
Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency
More information